Immuneering Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Immuneering Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Immuneering Corp Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $3.75M, a 8.21% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.75M -$335K -8.21% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $3.83M -$366K -8.73% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $3.91M -$396K -9.22% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $4M -$412K -9.35% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $4.08M -$429K -9.51% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.19M -$497K -10.6% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $4.3M -$530K -11% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $4.41M -$916K -17.2% Dec 31, 2022 10-K 2024-03-01
Q3 2022 $4.51M +$3.98M +740% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $4.69M +$4.13M +734% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $4.83M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $5.32M +$4.71M +768% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $537K Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $563K Jun 30, 2021 10-Q 2021-09-09
Q4 2020 $613K Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.